SEC Form 4 · accession 0001209191-18-049987
GYRE THERAPEUTICS, INC. · GYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Hill
Director
Period of report
Sep 6, 2018
Accepted (ET)
Sep 6, 2018 · 9:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 6, 2018 | D | 190 | $10.07 | D | 1,190 | D |
Table II — derivative securities
No Table II lines on this filing.